## Abstract The administration of synthetic steroid copies is one of the most important issues facing sports. Doping control laboratories accredited by the World Anti‐Doping Agency (WADA) require methods of analysis that allow endogenous steroids to be distinguished from their synthetic analogs in
Emerging drugs: mechanism of action, mass spectrometry and doping control analysis
✍ Scribed by Mario Thevis; Andreas Thomas; Maxie Kohler; Simon Beuck; Wilhelm Schänzer
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 400 KB
- Volume
- 44
- Category
- Article
- ISSN
- 1076-5174
- DOI
- 10.1002/jms.1584
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The number of compounds and doping methods in sports is in a state of constant flux. In addition to ‘traditional’ doping agents, such as anabolic androgenic steroids or erythropoietin, new therapeutics and emerging drugs have considerable potential for misuse in elite sport. Such compounds are commonly based on new chemical structures, and the mechanisms underlying their modes of action represent new therapeutic approaches arising from recent advances in medical research; therefore, sports drug testing procedures need to be continuously modified and complementary methods developed, preferably based on mass spectrometry, to enable comprehensive doping controls. This tutorial not only discusses emerging drugs that can be categorized as anabolic agents (selective androgen receptor modulators, SARMs), gene doping [hypoxia‐inducible factor stabilizers, peroxisome‐proliferator‐activated receptor (PPAR)δ‐agonists] and erythropoietin‐mimetics (Hematide) but also compounds with potentially performance‐enhancing properties that are not classified in the current list of the World Anti‐Doping Agency. Compounds such as ryanodine‐calstabin‐complex modulators (benzothiazepines) are included, their mass spectrometric properties discussed, and current approaches in sports drug testing outlined. Copyright © 2009 John Wiley & Sons, Ltd.
📜 SIMILAR VOLUMES
## Abstract A new doping control screening method has been developed, for the analysis of doping agents in human urine, using HPLC/orbitrap with in‐source collision‐induced dissociation and atmospheric pressure chemical ionization. The developed method allows the detection of 29 compounds, includin
septum, and inlet purge rates. The advantages of rapid automatic inlections along with specific recommendations for splitless injections into narrow-bore columns also appear in the literature [3,4,7,16,17] Theimportance ofm~ectionportlinerpreparation for certain compounds such as underlvatlzed drugs
## Abstract | I. | Introduction | 195 | | II. | Automated Sample Preparation | 197 | | | A. Sample Collection | 197 | | | B. Sample Pooling | 197 | | | C. Off‐Line Sample Preparation | 199 | | | D. On‐Line Sample Preparation | 200 | | | 1. Drirect Plasma Injection | 201 | | |
## Abstract The discovery of the designer steroid tetrahydrogestrinone (THG) in elite athletes' doping control samples in 2003 demonstrated the availability of steroid derivatives prepared solely for doping purposes. Modern mass spectrometers utilizing electrospray ionization and collisionally acti
## Abstract Testosterone (T) is the primary male sex hormone. In addition to the development of secondary sex characteristics, testosterone has anabolic effects including increases in muscle size and strength and increases in lean body mass, making it an attractive candidate to enhance athletic per